HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Jan Marini responds to Latisse

This article was originally published in The Rose Sheet

Executive Summary

Marini Lash Eyelash Conditioner "is a safe and cost-effective alternative to the new prescription-based Latisse product by Allergan for consumers seeking dense, lush-looking lashes," according to Jan. 22 release from Jan Marini Skin Research, which provides a head-to-head comparison of the two products. For example, one year of Latisse (12 monthly applications at $120 apiece) costs roughly $1,440, while a year's supply of Marini Lash (two 0.23 oz., $160 tubes) costs $320. JMSR notes that neither Marini Lash nor its companion product, Marini Mascara Performance Mascara, contain bimatoprost - the active drug in Latisse that was used first in an Allergan glaucoma treatment - though an earlier-generation Marini eyelash enhancer did (1"The Rose Sheet" Dec. 15, 2008, p. 7). "With Marini Lash, anyone can have thicker and lusher-appearing lashes without the substantial cost or warning labels that accompany the Latisse prescription product," the company says, adding that it "is also fantastic for eyebrows." Allergan has launched a multi-pronged campaign to raise consumer awareness of Latisse, the only eyelash enhancer with FDA's stamp of approval (2"The Rose Sheet" Jan. 12, 2009, p. 3)
Advertisement

Related Content

Advertisement
UsernamePublicRestriction

Register

RS015919

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel